TY - JOUR
KW - Adult
KW - Analgesics, Opioid/adverse effects
KW - Attention Deficit Disorder with Hyperactivity/diagnosis/epidemiology
KW - Female
KW - Humans
KW - Male
KW - Norway
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Self Report
KW - Street Drugs/adverse effects
KW - Surveys and Questionnaires
KW - attention deficit hyperactivity disorder
KW - mental health problems
KW - opioid dependence
KW - opioid maintenance treatment
AU - Fiksdal Abel
AU - E. Ravndal
AU - T. Clausen
AU - J. G. Bramness
A1 - 
AD - Norwegian Centre for Addiction Research (SERAF), Faculty of Medicine, Oslo, Norway.; Norwegian Centre for Addiction Research (SERAF), Faculty of Medicine, Oslo, Norway.; Norwegian Centre for Addiction Research (SERAF), Faculty of Medicine, Oslo, Norway.; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Oslo, Norway.
BT - European addiction research
C5 - Opioids & Substance Use
CP - 6
CY - Switzerland
DO - 10.1159/000484240
IS - 6
JF - European addiction research
M1 - Journal Article
PB - S. Karger AG, Basel
PP - Switzerland
PY - 2017
SN - 1421-9891; 1022-6877
SP - 298
EP - 305
EP - 
T1 - Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment
T2 - European addiction research
TI - Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment
U1 - Opioids & Substance Use
U2 - 29320768
U3 - 10.1159/000484240
VL - 23
VO - 1421-9891; 1022-6877
Y1 - 2017
ER -